Trial
NCT01409031
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); State University of New York at Buffalo; Vanderbilt University; Ann & Robert H Lurie Children's Hospital of Chicago; University of Utah; University of Alabama at Birmingham
Condition
Persistent Pulmonary Hypertension
Intervention
Intravenous Sildenafil
Why stopped
This trial was terminated early due to lack of recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-01